Celldex Therapeutics sell Barclays PLC
Start price
13.10.25
/
50%
€23.20
Target price
13.10.26
€21.52
Performance (%)
-15.52%
Price
20.02.26
€19.80
Summary
This prediction is currently active. The prediction for Celldex Therapeutics shows a convincing performance of -15.52%. This prediction currently runs until 13.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 1.020% | 1.020% |
| iShares Core DAX® | 1.432% | 2.628% |
| iShares Nasdaq 100 | 1.892% | -0.458% |
| iShares Nikkei 225® | -1.619% | 11.097% |
| iShares S&P 500 | 1.921% | 1.159% |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $25.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
-9.17%
20.02.26
20.02.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
-4.81%
20.02.26
20.02.26